Lifevantage Corp
- Nasdaq
- LFVN
- CIK
- 849146
- Industry
- Pharmaceutical Preparations
- Based in
- Lehi, Utah
- Fiscal year ends
- December 31
- SEC filer category
- Accelerated filer, Smaller reporting company
- Employer ID (EIN)
- 90-0224471
- Formerly
- Lifeline Therapeutics, Inc., Yaak River Resources Inc
Key figures
| Fiscal year to | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
| Revenue | $182.6M | $228.5M | $200.2M | $213.4M | $206.4M |
| Operating income | $6.10M | $12.2M | $4.33M | $4.26M | $7.58M |
| Net income | $5.07M | $9.80M | $2.94M | $2.54M | $3.12M |
| Diluted EPS | $0.40 | $0.75 | $0.23 | $0.20 | $0.24 |
| Cash from operations | $10.2M | $11.9M | $12.2M | $6.83M | $7.96M |
| Total assets | $62.1M | $72.0M | $60.3M | $66.1M | $70.7M |
| Shareholders’ equity | $33.6M | $34.6M | $26.0M | $34.6M | $31.5M |
From the company’s annual reports to the SEC. Each year links to its report.
Financials 96
- 10-Q Quarterly Report for period ending Sep 30, 2026
- 10-K Annual Report for period ending Jun 30, 2026
- 10-Q Quarterly Report for period ending Mar 31, 2026
- 10-Q Quarterly Report for period ending Dec 31, 2025
- 10-Q Quarterly Report for period ending Sep 30, 2025
- 10-K Annual Report for period ending Jun 30, 2025
- 10-Q Quarterly Report for period ending Mar 31, 2025
- 10-Q Quarterly Report for period ending Dec 31, 2024
- 10-Q Quarterly Report for period ending Sep 30, 2024
- 10-K Annual Report for period ending Jun 30, 2024
News 301
Ownership 719
- 4 Change in insider ownership
- 144 Notice of proposed sale of restricted stock
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- SCHEDULE 13G/A Major shareholder report (passive investor)
- 4 Change in insider ownership
- 4 Change in insider ownership
Prospectus 29
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-3 Registration statement for specified transactions by certain issuers
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-3 Registration statement for specified transactions by certain issuers
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-3 Registration statement for specified transactions by certain issuers
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Proxies 69
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DFAN14A Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
- DFAN14A Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DFAN14A Definitive additional proxy soliciting materials filed by non-management including Rule 14(a)(12) material
Other 105
- ARS Annual report to security holders
- EFFECT Notice of Effectiveness
- CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
- UPLOAD Letter (PDF)
- ARS Annual report to security holders
- ARS Annual report to security holders
- UPLOAD Letter (PDF)
- ARS Annual report to security holders
- 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
- EFFECT Notice of Effectiveness